chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills). At the time of the report, CHILLS (Chills) outcome was unknown.            No concomitant medication was mentioned. No treatment medication was mentioned.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Erythema, Pain
Clinical narrative: red mark was rectangle/ reaction in his arm/a little red round/ circle is little bigger than the one he got after his second dose; pain; chills; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red mark was rectangle/ reaction in his arm/a little red round/ circle is little bigger than the one he got after his second dose), PAIN (pain) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (red mark was rectangle/ reaction in his arm/a little red round/ circle is little bigger than the one he got after his second dose), PAIN (pain) and CHILLS (chills). At the time of the report, ERYTHEMA (red mark was rectangle/ reaction in his arm/a little red round/ circle is little bigger than the one he got after his second dose), PAIN (pain) and CHILLS (chills) outcome was unknown.            No concomitant medications was reported. Treatment medications was not provided.   This case was linked to MOD-2021-142236 (Patient Link).
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Muscle spasms, Vomiting
Clinical narrative: Breaking out in sweats; Muscles cramping up in legs/Muscles cramping up in stomach; Chills; Vomiting real bad/Vomiting a lot; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Breaking out in sweats), MUSCLE SPASMS (Muscles cramping up in legs/Muscles cramping up in stomach), CHILLS (Chills) and VOMITING (Vomiting real bad/Vomiting a lot) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F214) for COVID-19 vaccination.    Co-suspect product included non-company product ELECTROLYTES NOS for Dehydration.    No Medical History information was reported.   On 09-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started ELECTROLYTES NOS (unknown route) at an unspecified dose. On 10-Sep-2021 at 4:30 AM, the patient experienced HYPERHIDROSIS (Breaking out in sweats), MUSCLE SPASMS (Muscles cramping up in legs/Muscles cramping up in stomach), CHILLS (Chills) and VOMITING (Vomiting real bad/Vomiting a lot). The patient was treated with VITAMIN D NOS at an unspecified dose and frequency and VITAMIN C [ASCORBIC ACID] at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (Breaking out in sweats), MUSCLE SPASMS (Muscles cramping up in legs/Muscles cramping up in stomach), CHILLS (Chills) and VOMITING (Vomiting real bad/Vomiting a lot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient is on no concomitant medication reported by reporter.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Got COVID-19 Disease a few days after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got COVID-19 Disease a few days after vaccination) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In August 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced COVID-19 (Got COVID-19 Disease a few days after vaccination). At the time of the report, COVID-19 (Got COVID-19 Disease a few days after vaccination) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient Received Monoclonal Antibody infusion.  No concomitant medication was provided by reporter.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity, Peripheral swelling
Clinical narrative: Left arm swelled; These pains moved to my legs/I have pains in both calves/leg,calf pains; Terrible pains in my body; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Left arm swelled), PAIN IN EXTREMITY (These pains moved to my legs/I have pains in both calves/leg,calf pains) and MYALGIA (Terrible pains in my body) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007C21A and 016B21A) for COVID-19 vaccination.     Concurrent medical conditions included Fibromyalgia and Neuropathy.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced PAIN IN EXTREMITY (These pains moved to my legs/I have pains in both calves/leg,calf pains) and MYALGIA (Terrible pains in my body). On 22-Apr-2021, the patient experienced PERIPHERAL SWELLING (Left arm swelled). At the time of the report, PERIPHERAL SWELLING (Left arm swelled), PAIN IN EXTREMITY (These pains moved to my legs/I have pains in both calves/leg,calf pains) and MYALGIA (Terrible pains in my body) outcome was unknown.            No concomitant products were reported. No treatment drugs were reported.   This case was linked to MOD-2021-315529 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Sep-2021: Significant Follow up, current condition updated.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered past the 30 day refrigeration time; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered past the 30 day refrigeration time) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A and 047B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered past the 30 day refrigeration time). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered past the 30 day refrigeration time) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: more than 36 days have passed since the first dose and patient did not receive the second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (more than 36 days have passed since the first dose and patient did not receive the second dose) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (more than 36 days have passed since the first dose and patient did not receive the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (more than 36 days have passed since the first dose and patient did not receive the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and medication information provided.  No treatment information provided.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Chills, Erythema, Pruritus, Tenderness, Vaccination complication
Clinical narrative: Reaction in his arm; Little red round; little tender; Itchy; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Reaction in his arm), ERYTHEMA (Little red round), TENDERNESS (little tender), PRURITUS (Itchy) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Medical history was not provided.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Reaction in his arm), ERYTHEMA (Little red round), TENDERNESS (little tender), PRURITUS (Itchy) and CHILLS (Chills). At the time of the report, VACCINATION COMPLICATION (Reaction in his arm), ERYTHEMA (Little red round), TENDERNESS (little tender) and PRURITUS (Itchy) was resolving and CHILLS (Chills) outcome was unknown.            No concomitant medications were provided by the reporter. The patient had a dermatological cream which he has used to treat the symptoms. The patient mentioned that the circle was little bigger than the one he got after his second dose.   This case was linked to MOD-2021-142236 (Patient Link).
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Asthenia, Decreased appetite, Dizziness, Dysstasia
Clinical narrative: loss of appetite; loss of taste,; loss of energy; so dizzy; couldn't stand; body aches; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (loss of appetite), AGEUSIA (loss of taste,), ASTHENIA (loss of energy), DIZZINESS (so dizzy) and DYSSTASIA (couldn't stand) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (loss of appetite), AGEUSIA (loss of taste,), ASTHENIA (loss of energy), DIZZINESS (so dizzy), DYSSTASIA (couldn't stand) and MYALGIA (body aches). At the time of the report, DECREASED APPETITE (loss of appetite), AGEUSIA (loss of taste,), ASTHENIA (loss of energy), DIZZINESS (so dizzy), DYSSTASIA (couldn't stand) and MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  The treatment information was unknown.   Reporter did not allow further contact
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: loss of appetite; loss of taste,; loss of energy; so dizzy; couldn't stand; body aches; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (loss of appetite), AGEUSIA (loss of taste,), ASTHENIA (loss of energy), DIZZINESS (so dizzy) and DYSSTASIA (couldn't stand) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (loss of appetite), AGEUSIA (loss of taste,), ASTHENIA (loss of energy), DIZZINESS (so dizzy), DYSSTASIA (couldn't stand) and MYALGIA (body aches). At the time of the report, DECREASED APPETITE (loss of appetite), AGEUSIA (loss of taste,), ASTHENIA (loss of energy), DIZZINESS (so dizzy), DYSSTASIA (couldn't stand) and MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  The treatment information was unknown.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Positive COVID-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SARS-COV-2 TEST POSITIVE (Positive COVID-19). At the time of the report, SARS-COV-2 TEST POSITIVE (Positive COVID-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient tested positive for COVID-19 one week before scheduled second dose. Concomitant and treatment medication was not provided. No treatment medication information was provided
Sex: M
Vaccine: COVID19
Symptoms: Prostate infection
Clinical narrative: Issue with prostate infection; This spontaneous case was reported by a consumer and describes the occurrence of PROSTATE INFECTION (Issue with prostate infection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Prostate infection in 2016.    In August 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced PROSTATE INFECTION (Issue with prostate infection). At the time of the report, PROSTATE INFECTION (Issue with prostate infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported .  The patient reported that the patient took the first dose of moderna 32 days ago. The second dose is pending. The patient also mentioned that two weeks back again patient experienced the same symptom. The patient is not clear that if this was a side effect of the vaccine.  The patient is taking antibiotics currently.; Sender's Comments: This case concerns a patient of unknown age and gender conservatively taken as "male" due to the medical history of prostate infection who experienced the unexpected event of prostate infection. The event occurred after the first dose of Spikevax. The medical history of prostate infection remains a confounder. The benefit-risk relationship of drug Spikevax is not affected by this report.  The event prostate infection doesn´t  seem to be serious by medical judgement and from a clinical or regulatory standpoint.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Poor quality product administered
Clinical narrative: administered past the 30 day refrigeration time; administered past the 30 day refrigeration time; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered past the 30 day refrigeration time) and POOR QUALITY PRODUCT ADMINISTERED (administered past the 30 day refrigeration time) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered past the 30 day refrigeration time) and POOR QUALITY PRODUCT ADMINISTERED (administered past the 30 day refrigeration time). On 18-Aug-2021, EXPIRED PRODUCT ADMINISTERED (administered past the 30 day refrigeration time) and POOR QUALITY PRODUCT ADMINISTERED (administered past the 30 day refrigeration time) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported. Date refrigerated on 20-Apr-2021.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: a patient who presented to them for their 2nd dose of the Moderna Covid-19 Vaccine, and she's 16 years old; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a patient who presented to them for their 2nd dose of the Moderna Covid-19 Vaccine, and she's 16 years old) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Aug-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a patient who presented to them for their 2nd dose of the Moderna Covid-19 Vaccine, and she's 16 years old). On 13-Aug-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a patient who presented to them for their 2nd dose of the Moderna Covid-19 Vaccine, and she's 16 years old) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug was provided. No treatment medications were reported.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Product dose omission issue, Pruritus, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Only recieved one dose; Arm started getting itchy in left arm which was injection arm; Had a red circle; Swelled up bigger than golf ball, took up her whole arm / three days later it started to puff up again; Other parts of her body were getting itchy, like her head and arms and legs / bruise was itchy; She had a bruise it's not just a bruise, it's itchy; It was warm to touch; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Other parts of her body were getting itchy, like her head and arms and legs / bruise was itchy), CONTUSION (She had a bruise it's not just a bruise, it's itchy), VACCINATION SITE WARMTH (It was warm to touch), PRODUCT DOSE OMISSION ISSUE (Only recieved one dose) and VACCINATION SITE PRURITUS (Arm started getting itchy in left arm which was injection arm) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced PRURITUS (Other parts of her body were getting itchy, like her head and arms and legs / bruise was itchy), CONTUSION (She had a bruise it's not just a bruise, it's itchy), VACCINATION SITE WARMTH (It was warm to touch), VACCINATION SITE PRURITUS (Arm started getting itchy in left arm which was injection arm), VACCINATION SITE ERYTHEMA (Had a red circle) and VACCINATION SITE SWELLING (Swelled up bigger than golf ball, took up her whole arm / three days later it started to puff up again). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Only recieved one dose). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. In April 2021, VACCINATION SITE WARMTH (It was warm to touch) had resolved. At the time of the report, PRURITUS (Other parts of her body were getting itchy, like her head and arms and legs / bruise was itchy) and VACCINATION SITE ERYTHEMA (Had a red circle) had not resolved and CONTUSION (She had a bruise it's not just a bruise, it's itchy), PRODUCT DOSE OMISSION ISSUE (Only recieved one dose), VACCINATION SITE PRURITUS (Arm started getting itchy in left arm which was injection arm) and VACCINATION SITE SWELLING (Swelled up bigger than golf ball, took up her whole arm / three days later it started to puff up again) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  The patient reported that three days post the events the region again started to puff up and itchiness keeps her awake at night. This was seen once a week since the first time she had swelling in arm.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: Only recieved one dose; Arm started getting itchy in left arm which was injection arm; Had a red circle; Swelled up bigger than golf ball, took up her whole arm / three days later it started to puff up again; Other parts of her body were getting itchy, like her head and arms and legs / bruise was itchy; She had a bruise it's not just a bruise, it's itchy; It was warm to touch; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Other parts of her body were getting itchy, like her head and arms and legs / bruise was itchy), CONTUSION (She had a bruise it's not just a bruise, it's itchy), VACCINATION SITE WARMTH (It was warm to touch), PRODUCT DOSE OMISSION ISSUE (Only recieved one dose) and VACCINATION SITE PRURITUS (Arm started getting itchy in left arm which was injection arm) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced PRURITUS (Other parts of her body were getting itchy, like her head and arms and legs / bruise was itchy), CONTUSION (She had a bruise it's not just a bruise, it's itchy), VACCINATION SITE WARMTH (It was warm to touch), VACCINATION SITE PRURITUS (Arm started getting itchy in left arm which was injection arm), VACCINATION SITE ERYTHEMA (Had a red circle) and VACCINATION SITE SWELLING (Swelled up bigger than golf ball, took up her whole arm / three days later it started to puff up again). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Only recieved one dose). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. In April 2021, VACCINATION SITE WARMTH (It was warm to touch) had resolved. At the time of the report, PRURITUS (Other parts of her body were getting itchy, like her head and arms and legs / bruise was itchy) and VACCINATION SITE ERYTHEMA (Had a red circle) had not resolved and CONTUSION (She had a bruise it's not just a bruise, it's itchy), PRODUCT DOSE OMISSION ISSUE (Only recieved one dose), VACCINATION SITE PRURITUS (Arm started getting itchy in left arm which was injection arm) and VACCINATION SITE SWELLING (Swelled up bigger than golf ball, took up her whole arm / three days later it started to puff up again) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  The patient reported that three days post the events the region again started to puff up and itchiness keeps her awake at night. This was seen once a week since the first time she had swelling in arm.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Neck pain, Vaccination site pain
Clinical narrative: Pain on his neck; Chills; Headache; Pain on his shoulder at the same arm of injection site; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Pain on his neck), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE PAIN (Pain on his shoulder at the same arm of injection site) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), LOSARTAN and PANTOPRAZOLE for an unknown indication.    On 10-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Sep-2021, the patient experienced NECK PAIN (Pain on his neck), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE PAIN (Pain on his shoulder at the same arm of injection site). At the time of the report, NECK PAIN (Pain on his neck), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE PAIN (Pain on his shoulder at the same arm of injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided by the reporter.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Vaccination complication
Clinical narrative: Missed the 2nd shot (7 months post 1st shot); Had side effects after first shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had side effects after first shot) and PRODUCT DOSE OMISSION ISSUE (Missed the 2nd shot (7 months post 1st shot)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced VACCINATION COMPLICATION (Had side effects after first shot). On 10-Sep-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed the 2nd shot (7 months post 1st shot)). On 10-Sep-2021, PRODUCT DOSE OMISSION ISSUE (Missed the 2nd shot (7 months post 1st shot)) had resolved. At the time of the report, VACCINATION COMPLICATION (Had side effects after first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication provided. No treatment information mentioned.  Patient called in to report that she missed the second dose and it has been 7 months since. Mentioned having some side effects to first dose and says she reported it so did not provide details now.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient today who received their first Covid vaccine dose today however the vial had been in the refrigerator for 31 days/it was 1 day past beyond use date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient today who received their first Covid vaccine dose today however the vial had been in the refrigerator for 31 days/it was 1 day past beyond use date) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient today who received their first Covid vaccine dose today however the vial had been in the refrigerator for 31 days/it was 1 day past beyond use date). On 10-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Patient today who received their first Covid vaccine dose today however the vial had been in the refrigerator for 31 days/it was 1 day past beyond use date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not provided.   Reporter did not allow further contact
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product administered to patient of inappropriate age
Clinical narrative: Dose administered 20 hours after punctured; Dose administered to 16 year old; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered 20 hours after punctured) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Dose administered to 16 year old) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Sep-2021 at 11:00 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered 20 hours after punctured) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Dose administered to 16 year old). On 10-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Dose administered 20 hours after punctured) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Dose administered to 16 year old) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided.  It was reported that vial was initially punctured on 09-Sep-2021 at 3 P.M . It was stored at room temperature post puncture for about 20 hours. The vial did not undergo any temperature excursions.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Chronic obstructive pulmonary disease
Clinical narrative: COVID-19; COPD; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) and CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19) and CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). At the time of the report, COVID-19 (COVID-19) and CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) outcome was unknown.            No concomitant medication is provided by reporter. No treatment was provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered 9 doses of expired Moderna to patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered 9 doses of expired Moderna to patients) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered 9 doses of expired Moderna to patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered 9 doses of expired Moderna to patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided   Reporter did not allow further contact
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Numbness in left leg; This spontaneous case was reported by a pharmacist and describes the occurrence of HYPOAESTHESIA (Numbness in left leg) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Numbness in left leg). At the time of the report, HYPOAESTHESIA (Numbness in left leg) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 10-Sep-2021: Follow-up contains Reporter's Email address Updated.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Heart rate, Pain, Pyrexia, Rhinorrhoea
Clinical narrative: Runny nose after 2nd shot; Radiating pain after 2nd shot; Fever 102 F after 2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose after 2nd shot), PAIN (Radiating pain after 2nd shot) and PYREXIA (Fever 102 F after 2nd shot) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     The patient's past medical history included Cardiac arrhythmia (NOS). Concurrent medical conditions included Immunocompromised and Asthma. Concomitant products included SALBUTAMOL SULFATE (PROAIR HFA) and TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA) for Asthma.    On 07-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced RHINORRHOEA (Runny nose after 2nd shot), PAIN (Radiating pain after 2nd shot) and PYREXIA (Fever 102 F after 2nd shot). The patient was treated with PARACETAMOL (TYLENOL) on 07-Apr-2021 for Pain, at an unspecified dose and frequency. On 08-Apr-2021, RHINORRHOEA (Runny nose after 2nd shot) and PYREXIA (Fever 102 F after 2nd shot) had resolved. On 09-Apr-2021, PAIN (Radiating pain after 2nd shot) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Apr-2021, Body temperature: 102 (High) high. On an unknown date, Heart rate: abnormal (abnormal) irregular.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had radiating pain for 2.5 days   This case was linked to MOD-2021-315707, MOD-2021-315546 (Patient Link).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Body temperature, Chest discomfort, Chest pain, Chills
Clinical narrative: Back pain is bad and waking her up last night, radiating pain; Chest hurts after 3rd shot; Chest feels tight after 3rd shot; Feel cold after 3rd shot; Chills after 3rd shot; Body Aches after 3rd shot; Fever 102F after 3rd shot; Headache after 3rd shot; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain is bad and waking her up last night, radiating pain), CHEST PAIN (Chest hurts after 3rd shot), CHEST DISCOMFORT (Chest feels tight after 3rd shot), FEELING COLD (Feel cold after 3rd shot) and CHILLS (Chills after 3rd shot) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart rate abnormal (irregular heart beat) and COVID-19 in January 2021. Concurrent medical conditions included Asthma and Immunocompromised (not specified). Concomitant products included SALBUTAMOL SULFATE (PROAIR HFA) and TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA) for Asthma.    On 09-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced BACK PAIN (Back pain is bad and waking her up last night, radiating pain), CHEST PAIN (Chest hurts after 3rd shot), CHEST DISCOMFORT (Chest feels tight after 3rd shot), FEELING COLD (Feel cold after 3rd shot), CHILLS (Chills after 3rd shot), MYALGIA (Body Aches after 3rd shot), PYREXIA (Fever 102F after 3rd shot) and HEADACHE (Headache after 3rd shot). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, BACK PAIN (Back pain is bad and waking her up last night, radiating pain), CHEST PAIN (Chest hurts after 3rd shot), CHEST DISCOMFORT (Chest feels tight after 3rd shot), FEELING COLD (Feel cold after 3rd shot), CHILLS (Chills after 3rd shot), MYALGIA (Body Aches after 3rd shot), PYREXIA (Fever 102F after 3rd shot) and HEADACHE (Headache after 3rd shot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Sep-2021, Body temperature: 102 (High) Fever 102F.         This case was linked to MOD-2021-315546, MOD-2021-315706 (Patient Link).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Headache, Myalgia, Pyrexia
Clinical narrative: Back pain is bad and waking her up last night, radiating pain; Chest hurts after 3rd shot; Chest feels tight after 3rd shot; Feel cold after 3rd shot; Chills after 3rd shot; Body Aches after 3rd shot; Fever 102F after 3rd shot; Headache after 3rd shot; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain is bad and waking her up last night, radiating pain), CHEST PAIN (Chest hurts after 3rd shot), CHEST DISCOMFORT (Chest feels tight after 3rd shot), FEELING COLD (Feel cold after 3rd shot) and CHILLS (Chills after 3rd shot) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart rate abnormal (irregular heart beat) and COVID-19 in January 2021. Concurrent medical conditions included Asthma and Immunocompromised (not specified). Concomitant products included SALBUTAMOL SULFATE (PROAIR HFA) and TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA) for Asthma.    On 09-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced BACK PAIN (Back pain is bad and waking her up last night, radiating pain), CHEST PAIN (Chest hurts after 3rd shot), CHEST DISCOMFORT (Chest feels tight after 3rd shot), FEELING COLD (Feel cold after 3rd shot), CHILLS (Chills after 3rd shot), MYALGIA (Body Aches after 3rd shot), PYREXIA (Fever 102F after 3rd shot) and HEADACHE (Headache after 3rd shot). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, BACK PAIN (Back pain is bad and waking her up last night, radiating pain), CHEST PAIN (Chest hurts after 3rd shot), CHEST DISCOMFORT (Chest feels tight after 3rd shot), FEELING COLD (Feel cold after 3rd shot), CHILLS (Chills after 3rd shot), MYALGIA (Body Aches after 3rd shot), PYREXIA (Fever 102F after 3rd shot) and HEADACHE (Headache after 3rd shot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Sep-2021, Body temperature: 102 (High) Fever 102F.         This case was linked to MOD-2021-315546, MOD-2021-315706 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: I would like to know whats the side after getting the first dose and time of those effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I would like to know whats the side after getting the first dose and time of those effects) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (I would like to know whats the side after getting the first dose and time of those effects). At the time of the report, VACCINATION COMPLICATION (I would like to know whats the side after getting the first dose and time of those effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication were reported. No concomitant medication were reported.
Age: 17.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: had my first dose of moderna today and im 17; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (had my first dose of moderna today and im 17) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (had my first dose of moderna today and im 17). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (had my first dose of moderna today and im 17) had resolved.            No concomitant medication reported. No treatment medication reported.
Sex: U
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: I had my third shot yesterday ND MY CHECT IS VERY SORE TODAYCAN'T EVEN TOUCH IT; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (I had my third shot yesterday ND MY CHECT IS VERY SORE TODAYCAN'T EVEN TOUCH IT) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (I had my third shot yesterday ND MY CHECT IS VERY SORE TODAYCAN'T EVEN TOUCH IT). At the time of the report, CHEST PAIN (I had my third shot yesterday ND MY CHECT IS VERY SORE TODAYCAN'T EVEN TOUCH IT) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Sore arm; Fatigue; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue). At the time of the report, PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue) outcome was unknown.            No Concomitant medications were reported. No Treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Fatigue, Injection site urticaria, Pain in extremity, Pyrexia
Clinical narrative: large welt in the injection site; sore in the arm; fever (101,5 °F); chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE URTICARIA (large welt in the injection site), PAIN IN EXTREMITY (sore in the arm), PYREXIA (fever (101,5 °F)), CHILLS (chills) and FATIGUE (fatigue) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE URTICARIA (large welt in the injection site), PAIN IN EXTREMITY (sore in the arm), PYREXIA (fever (101,5 °F)), CHILLS (chills) and FATIGUE (fatigue). At the time of the report, INJECTION SITE URTICARIA (large welt in the injection site), PAIN IN EXTREMITY (sore in the arm), PYREXIA (fever (101,5 °F)), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.            No concomitant medications was provided by the reporter.  The patient had a temperature of 101.5.     No treatments medications was provided by the reporter.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 2nd dose administered to a 16 year old; 1st dose administered to a 16 year old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1st dose administered to a 16 year old) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (2nd dose administered to a 16 year old) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 037B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Aug-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1st dose administered to a 16 year old). On 10-Sep-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (2nd dose administered to a 16 year old). On 12-Aug-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1st dose administered to a 16 year old) had resolved. On 10-Sep-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (2nd dose administered to a 16 year old) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter.  No treatment information was provided.